|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-3-17
|
|
pubmed:abstractText |
Intravenous erythromycin has previously been reported to stimulate gastric emptying, to inhibit gastric acid secretion and to stimulate pancreatic secretion during continuous gastric infusion of a liquid diet in healthy volunteers.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
967-73
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8971296-Administration, Oral,
pubmed-meshheading:8971296-Adult,
pubmed-meshheading:8971296-Biliary Tract,
pubmed-meshheading:8971296-Cecum,
pubmed-meshheading:8971296-Cross-Over Studies,
pubmed-meshheading:8971296-Double-Blind Method,
pubmed-meshheading:8971296-Duodenum,
pubmed-meshheading:8971296-Enteral Nutrition,
pubmed-meshheading:8971296-Erythromycin,
pubmed-meshheading:8971296-Gastric Emptying,
pubmed-meshheading:8971296-Gastric Mucosa,
pubmed-meshheading:8971296-Gastrointestinal Agents,
pubmed-meshheading:8971296-Gastrointestinal Transit,
pubmed-meshheading:8971296-Humans,
pubmed-meshheading:8971296-Lipase,
pubmed-meshheading:8971296-Male,
pubmed-meshheading:8971296-Pancreas
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Could oral erythromycin optimize high energy continuous enteral nutrition?
|
|
pubmed:affiliation |
Laboratoire de Pharmacie Galénique, Faculté de Pharmacie, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
